These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3324648)

  • 1. Citalopram versus maprotiline: a controlled, clinical multicentre trial in depressed patients.
    Bouchard JM; Delaunay J; Delisle JP; Grasset N; Mermberg PF; Molczadzki M; Pagot R; Richou H; Robert G; Ropert R
    Acta Psychiatr Scand; 1987 Nov; 76(5):583-92. PubMed ID: 3324648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients.
    Timmerman L; de Beurs P; Tan BK; Leijnse-Ybema H; Sanchez C; Høpfner Petersen HE; Cohen Stuart MH
    Int Clin Psychopharmacol; 1987 Jul; 2(3):239-53. PubMed ID: 2447151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citalopram versus mianserin. A controlled, double-blind trial in depressed patients.
    de Wilde J; Mertens C; Overø KF; Petersen HE
    Acta Psychiatr Scand; 1985 Jul; 72(1):89-96. PubMed ID: 3898725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. A preliminary study.
    Møller SE; de Beurs P; Timmerman L; Tan BK; Leijnse-Ybema HJ; Stuart MH; Petersen HE
    Psychopharmacology (Berl); 1986; 88(1):96-100. PubMed ID: 3080781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind trial comparing mianserin and maprotiline in depressed inpatients.
    Palha AP; Ferreira L; Abreu-Lima C; Ramalhão C; Fernandes R
    Clin Ther; 1985; 7(5):584-92. PubMed ID: 3902238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients.
    Gravem A; Amthor KF; Astrup C; Elgen K; Gjessing LR; Gunby B; Pettersen RD; Kyrdalen L; Vaadal J; Ofsti E
    Acta Psychiatr Scand; 1987 May; 75(5):478-86. PubMed ID: 3300171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone suppression test and the response to antidepressant depending on their central monoaminergic action in major depression.
    Benkelfat C; Poirier MF; Léouffre P; Gay C; Löo H
    Can J Psychiatry; 1987 Apr; 32(3):175-8. PubMed ID: 3471304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between blood concentrations and clinical effects of a new antidepressant "maprotiline".
    Watanabe S; Yokoyama S; Kubo S; Iwai H; Kuyama C
    Folia Psychiatr Neurol Jpn; 1980; 34(2):147-56. PubMed ID: 7007180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Citalopram. An open study of a highly selective serotonin-uptake inhibitor administered by infusion to depressive patients].
    Charbonnier JF; Reboul P; Rougier M; Aubin B; Chassaing JL; Philippe P; Planche R; Hoepfner Petersen HE
    Encephale; 1987; 13(4):249-54. PubMed ID: 3311709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.
    Kasper S; Voll G; Vieira A; Kick H
    Pharmacopsychiatry; 1990 May; 23(3):135-42. PubMed ID: 2115680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes.
    Eberhard G; von Knorring L; Nilsson HL; Sundequist U; Björling G; Linder H; Svärd KO; Tysk L
    Neuropsychobiology; 1988; 19(1):25-34. PubMed ID: 3054623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomifensine and maprotiline in endogenous depression: comparative efficacy and side effects.
    Levin A
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():89-96. PubMed ID: 6752081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people.
    Schifano F; Garbin A; Renesto V; De Dominicis MG; Trinciarelli G; Silvestri A; Magni G
    Acta Psychiatr Scand; 1990 Mar; 81(3):289-94. PubMed ID: 2188479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-over trial comparing the antidepressant effects of amineptine and maprotiline.
    Bornstein S
    Curr Med Res Opin; 1979; 6(2):107-10. PubMed ID: 380910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial.
    Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
    Clin Ther; 1980; 3(4):292-310. PubMed ID: 7023677
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
    Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
    J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recurrence of unipolar depression and efficacy of maprotiline].
    Rouillon F; Phillips R; Serrurier D; Ansart E; Gérard MJ
    Encephale; 1989; 15(6):527-34. PubMed ID: 2693074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemistry, pharmacology, pharmacokinetics, adverse effects, and efficacy of the antidepressant maprotiline hydrochloride.
    Wells BG; Gelenberg AJ
    Pharmacotherapy; 1981; 1(2):121-39. PubMed ID: 6765485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citalopram--a highly selective 5-HT uptake inhibitor--in the treatment of depressed patients.
    Dufour H; Bouchacourt M; Thermoz P; Viala A; Phak Rop P; Gouezo F; Durand A; Høpfner Petersen HE
    Int Clin Psychopharmacol; 1987 Jul; 2(3):225-37. PubMed ID: 3320186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.